Regen Biopharma, Inc. Stock Price - RGBP

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Ultimate Trader
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Regen Biopharma, Inc. (QB) RGBP OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.0003 0.0003 0.000197 0.0003 0.0003 17:00:12
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
43 131,538,705 $ 0.000226 $ 29,675 19,473,345 0.000197 - 0.0095
Last Trade Time Type Quantity Stock Price Currency
16:32:17 average 25,000,000 $ 0.00019 USD

Regen Biopharma, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 219.45k 731.51M $ -7.75M - - 213.90M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Regen Biopharma, Inc. News

Loading Messages....

Latest RGBP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGBP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00050.00060.0001970.00039481,387,878-0.0002-40.0%
1 Month0.00050.00060.0001970.000413832,811,209-0.0002-40.0%
3 Months0.00090.00190.0001970.000740220,461,951-0.0006-66.67%
6 Months0.0010.00290.0001970.000991317,248,990-0.0007-70.0%
1 Year0.00450.00950.0001970.001322513,459,803-0.0042-93.33%
3 Years0.080.127720.0001970.00254624,852,607-0.0797-99.63%
5 Years0.130.4480.0001970.00485122,962,273-0.1297-99.77%

Regen Biopharma, Inc. Description

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.